A detailed history of Joseph Group Capital Management transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Joseph Group Capital Management holds 2,525 shares of MEDP stock, worth $850,622. This represents 0.62% of its overall portfolio holdings.

Number of Shares
2,525
Previous 2,250 12.22%
Holding current value
$850,622
Previous $909,000 14.3%
% of portfolio
0.62%
Previous 0.52%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$372.0 - $424.34 $102,300 - $116,693
275 Added 12.22%
2,525 $1.04 Million
Q1 2024

May 13, 2024

SELL
$284.87 - $413.31 $138,161 - $200,455
-485 Reduced 17.73%
2,250 $909,000
Q4 2023

Feb 13, 2024

SELL
$227.52 - $312.68 $30,715 - $42,211
-135 Reduced 4.7%
2,735 $838,000
Q3 2023

Nov 13, 2023

SELL
$233.98 - $281.67 $74,873 - $90,134
-320 Reduced 10.03%
2,870 $694,000
Q2 2023

Aug 10, 2023

BUY
$187.26 - $240.17 $8,239 - $10,567
44 Added 1.4%
3,190 $766,000
Q1 2023

May 04, 2023

BUY
$174.31 - $239.52 $37,302 - $51,257
214 Added 7.3%
3,146 $591,000
Q4 2022

Feb 09, 2023

SELL
$153.06 - $226.57 $36,428 - $53,923
-238 Reduced 7.51%
2,932 $622,000
Q3 2022

Nov 09, 2022

BUY
$145.13 - $182.49 $34,105 - $42,885
235 Added 8.01%
3,170 $498,000
Q2 2022

Aug 10, 2022

BUY
$130.2 - $168.03 $45,179 - $58,306
347 Added 13.41%
2,935 $439,000
Q1 2022

May 11, 2022

BUY
$138.87 - $214.31 $18,330 - $28,288
132 Added 5.37%
2,588 $423,000
Q4 2021

Feb 11, 2022

BUY
$182.74 - $227.9 $438,210 - $546,504
2,398 Added 4134.48%
2,456 $535,000
Q4 2021

Feb 10, 2022

BUY
$182.74 - $227.9 $10,598 - $13,218
58 New
58 $535,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Joseph Group Capital Management Portfolio

Follow Joseph Group Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joseph Group Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Joseph Group Capital Management with notifications on news.